Skip to main content

Sakys John's Form 4 filing

Mesa Laboratories Inc (MLAB) · filed Dec 10, 2021

Accession no.
0001228924-21-000082
Filed
Dec 10, 2021
Trade date
Dec 10, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $570.9K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sakys JohnCIK 0001197710Officer (CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 10, 2021Common StockMOption exerciseAcquired+158$89.70+$14,172.67,672Direct
Dec 10, 2021Common StockMOption exerciseAcquired+1,600$97.78+$156,4489,272Direct
Dec 10, 2021Common StockSSaleDisposed−1,758$324.74−$570,892.927,514Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 10, 2021Common StockXIn-the-money exerciseDisposed−158$0.00$029,871Direct
Dec 10, 2021Common StockXIn-the-money exerciseDisposed−1,600$0.00$028,271Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)